Neovetera: A New Taxonomy of Human Flourishing in the Age of Epigenetic Medicine
"Neovetera is a philosophical and biological concept introduced by Shawn J. Rhynes in August 2026 naming the first human being to simultaneously embody biological youth and accumulated wisdom — the experienced veteran of life, reborn into vitality."
What is a Neovetera?A Neovetera is a human being who has undergone biological age rejuvenation through epigenetic reprogramming while retaining the full accumulated wisdom, experiential memory, relational depth, and psychological maturity of their chronological lifespan.The word combines two ancient roots — neo (Greek: new, young) and vetera (Latin: the experienced, the battle-hardened veteran of life). Together they name something evolution never produced: the experienced veteran of life, reborn into biological vitality.For the first time in human history, the fundamental tradeoff between vitality and wisdom — youth brought physical capacity but little wisdom, while old age brought wisdom alongside physical decline — is being resolved through epigenetic medicine.
The Formal TerminologyNeovetera— A human being who has undergone biological age rejuvenation while retaining the full accumulated wisdom, experiential memory, relational depth, and psychological maturity of their chronological lifespan. Plural: Neoveterae.Neoveteral — Of or relating to the state of being a Neovetera. The neoveteral condition. Neoveteral consciousness. Neoveteral biology.Neoveterism — The philosophical framework describing the convergence of biological vitality and accumulated wisdom as the optimal and now potentially achievable state of human flourishing.Neoveterancy — The quality or condition of being a Neovetera. The achievement of neoveterancy.Neoveterist — One who studies or practices within the philosophical framework of Neoveterism.
The Science Behind NeoveteraNeovetera emerges directly from advances in partial epigenetic reprogramming — specifically the OSK system developed by David Sinclair's lab at Harvard Medical School. OSK reprogramming resets the biological age of cells by restoring their epigenetic state toward a younger profile without erasing cellular identity.Life Biosciences' ER-100 — the world's first human clinical trial of partial epigenetic reprogramming — dosed its first patient on June 9, 2026. The Q4 2026 Phase 1 readout will be the first human data on whether biological age reversal is achievable in living human tissue.When it succeeds — and the preclinical data from mice and primates strongly suggests it will — the human beings who undergo whole-body epigenetic rejuvenation will need a name. That name is Neovetera.
About The AuthorShawn J. Rhynes is an independent scholar whose work spans financial analysis, investment research, and the philosophy of science. Formally educated in psychology and a lifelong student of biology, philosophy, and the history of ideas, Rhynes developed the concept of Neovetera in August 2026 through an extended interdisciplinary inquiry into the philosophical implications of epigenetic medicine.© 2026 Shawn J. Rhynes. All rights reserved. DOI: 10.5281/zenodo.21890822